Equities

Nordhealth AS

Nordhealth AS

Actions
Health CareHealth Care Providers
  • Price (NOK)37.50
  • Today's Change0.10 / 0.27%
  • Shares traded765.00
  • 1 Year change+52.44%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nordhealth AS is a Norway-based cloud-based healthcare Software-as-a-Service business. The Company's flagship products are Provet Cloud and Diarium, both cloud-based Practice Management Software for veterinarians and therapists, respectively. The Group serves over 7,000 clinics and hospitals located in over 25 countries. Nordhealth's mission is to build software that empowers healthcare professionals to improve patient care, increase efficiency and expand their business.

  • Revenue in NOK (TTM)503.95m
  • Net income in NOK-95.29m
  • Incorporated2021
  • Employees403.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Optomed Oyj156.89m-69.10m895.58m113.00--3.14--5.71-0.3355-0.33550.7631.260.42671.754.06119,307.00-18.79-12.95-22.82-15.9064.8065.69-44.04-27.842.76-20.420.1313--3.003.4718.84--7.26--
C Rad AB498.59m53.60m932.49m94.0017.853.1514.851.871.581.5814.728.961.235.042.725,712,816.0013.255.0919.167.0246.3043.1210.814.862.32--0.00490.0040.9217.44375.0510.8933.69--
Bactiguard Holding AB255.77m-56.29m1.07bn163.00--3.67--4.19-1.60-1.607.289.370.37063.847.601,174,917.00-8.16-7.56-11.32-8.8147.5347.91-22.01-26.280.5898-2.720.4175---11.966.46-161.71--8.43--
BioPorto A/S54.00m-94.83m1.08bn36.00--8.06--19.99-0.163-0.1630.09390.20140.33763.396.121,126,000.00-59.29-71.10-74.24-96.5570.6263.38-175.62-239.224.91-52.720.0507--6.873.5425.81---51.56--
Sedana Medical AB (publ)174.69m-57.42m1.19bn78.00--1.25--6.82-0.5763-0.57631.759.560.16971.1610.142,204,317.00-5.58-5.77-5.84-6.0870.6064.06-32.87-36.136.02-30.480.0076--25.2321.5918.90--42.12--
Paxman AB (publ)239.61m28.73m1.29bn102.0045.108.8427.465.401.501.5012.547.671.312.746.562,624,791.0015.66-5.0820.74-7.7670.2769.3811.99-5.071.9812.730.0838--43.9929.35180.69--6.26--
Nordhealth As503.95m-95.29m1.69bn403.00--3.3457.983.35-1.23-1.236.4711.160.475--9.491,275,833.00-8.98---10.01--85.89---18.91------0.00--18.60--21.96------
Stille AB488.97m51.02m1.83bn151.0032.082.7124.323.746.336.3360.9474.850.69782.108.494,598,368.007.287.038.708.1949.1743.9310.439.851.127.410.0021.9819.7016.78-2.485.3423.62--
Genovis AB130.14m28.00m1.84bn32.0065.798.2646.8814.150.42630.42631.983.390.4239----3,506,189.009.1218.569.8021.4564.6965.5121.5123.88----0.25550.0054.5435.56449.56--47.59--
Detection Technology Oyj-1.15tn-1.15tn2.32bn464.00--2.73----------5.03----------9.34--11.96--47.44--8.223.39--0.0053.455.292.027.55-18.03-14.88-9.55
BICO Group AB2.26bn-789.29m2.52bn828.00--0.8711--1.12-11.15-15.2031.9241.790.36022.154.472,547,964.00-12.62---14.44--55.70---35.03--2.23-0.57050.397--6.09---1,889.33------
Data as of Nov 22 2024. Currency figures normalised to Nordhealth AS's reporting currency: Norwegian Krone NOK

Institutional shareholders

33.28%Per cent of shares held by top holders
HolderShares% Held
Capital Research & Management Co. (World Investors)as of 30 Sep 20244.32m9.56%
Fj�rde AP-fondenas of 30 Jun 20243.27m7.24%
Pareto Asset Management ASas of 30 Jun 20242.17m4.79%
Herald Investment Management Ltd.as of 31 Dec 20231.36m3.01%
Capital Research & Management Co. (Global Investors)as of 30 Sep 20241.08m2.39%
Aktia Bank Plc (Investment Management)as of 31 Oct 2024925.00k2.05%
OP Asset Management Ltd.as of 30 Jun 2024630.31k1.40%
Laiqon AG (Investment Management)as of 30 Aug 2024586.46k1.30%
Schroder Investment Management Ltd.as of 31 Dec 2023501.00k1.11%
Barius Capital Management GmbHas of 28 Jun 2024200.45k0.44%
More ▼
Data from 28 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.